NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

NCT03647878

Active Not RecruitingN/A

Sponsor: Ipsen

Conditions: Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma

Countries: Austria, Germany

The purpose of the protocol, is to describe the use of cabozantinib tablets as monotherapy or in combination with nivolumab including the number of dose reductions, dose interruptions and terminations due to (serious) adverse events in subjects with advanced or metastatic renal cell carcinoma (mRCC) treated in real-life clinical setting in 1st line treatment.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Males or females aged 18 years and older with capacity to consent.
* Subjects receiving cabozantinib as monotherapy or in combination with nivolumab as a first line treatment for advanced or metastatic renal cell carcinoma
* Subjects with the intention to be treated with cabozantinib tablets as monotherapy or in combination with nivolumab according to the current local Summary of Product Characteristics (SmPC); decision has to be taken before entry in the study.
* Signed written informed consent

Exclusion Criteria:

* Participation in an interventional study at the same time and/or within 3 months before baseline.
* Previous participation in this study

Locations (82)

Leoben, Austria
Linz, Austria
Salzburg, Austria
Vöcklabruck, Austria
Wels, Austria
Aachen, Germany
Aachen, Germany
Aschaffenburg, Germany
Augsburg, Germany
Bad Homburg, Germany
Bad Liebenwerda, Germany
Bad Schlema, Germany
Bamberg, Germany
Bergisch Gladbach, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Bernburg, Germany
Bielefeld, Germany
Bremen, Germany
Bremen, Germany
Chemnitz, Germany
Cottbus, Germany
Donauwörth, Germany
Dresden, Germany
Dresden, Germany
+ 52 more on CT.gov